Despite Death Scare, Hospitals, Pharmacies Continue Dispense Of Amoxicillin
… Nigerian Drugs Market Complicated, Says Doctors
. As Nigerians Advocate Strengthening Of Drugs Regulations

BY CEES HARMON and ZAKA KHALIQ
Despite the suspension of a brand of Amoxicillin tablets by the National Agency for Food and Drugs Administration and Control (NAFDAC) over a year ago, cases of sevvere health crisis arising from intake of Amoxicillin drugs are now being reported in some hospitals across the country, BUSINESSDIARY can now reveal.
Although,the NAFDAC’s ban only applies to Deekins Amoxycillin 500mg produced by Ecomed Pharma Limited, a Nigerian pharmaceutical company, the recent cases are raising concerns on whether this brand still exisit in the market or another substandard or adulterated version of Amoxicillin has entered the Nigerian markets.
Most public and private hospitals in Lagos, Ogun, Osun, among other States of the federation dispense the drugs for treatment of infections and typhoid and are recommended by doctors as a follow-up drugs for recovering patients, BUSINESSDIARY learnt.
In situations where hospitals pharmacies doesn’t have, doctors do write Amoxicillin prescription for patients to get at pharmacy near them. Similarly, Nigerians who mostly do self-medication go to pharmacy near them to get the medicine as virtually every pharmacy has the antibiotics.
However, investigations show that, in recent times, patients that were treated with this drugs and discharged are now reporting back to their hospitals with more sever conditions, some at the point of death.
This development is unsettling the health sector as doctors and patients are at a loss on why this complications erupt.
Recall that NAFDAC had announced in 2024 and reaffirmed in 2025 the suspension of specific batches and brands of Amoxicillin for investigation, citing concerns over possible substandard or falsified products in circulation.
In a statement titled: ‘Public Alert No. 048/2024 -Alert on Recall of Deekins Amoxycillin 500mg Capsule Batch 4C639001,’ the agency had warned against the use of the Deekins Amoxicillin 500mg capsules due to its adverse effects on users.
NAFDAC then said, the Deekins Amoxicillin 500mg capsules with batch number 4C639001 were recalled by its manufacturer, Ecomed Pharma Limited, a Nigerian pharmaceutical company, after multiple reports of severe reactions.
The adverse drug reactions to such drugs, according to the agency, can have life-threatening consequences, including hospitalisation, significant disability, or even death.
The agency then warned health workers against dispensing the Deekin Amoxicillin capsule and the public against usage.
“An adverse reaction to drugs may be life-threatening, may require hospitalisation or prolongation of existing hospitalisation, result in persistent or significant disability or incapacity, or is a birth defect or death in fatal cases,” it said.
Although, not all Amoxicillin swere uspended then, as NAFDAC was specific about the brand of the drug suspended, however, over a year later, similar symptoms that led to evacuation of the drugs from the market now erupts. Whether the drugs causing this life threatening ailments is from the same manufacturer or some other dubious manufacturers cannot be ascertained as at the time of writing this report.
Meanwhile, public concern is mounting over reports that Amoxicillin prescribed for patients as follow-up medication in some Nigerian hospitals are returning with severe complications, including seizures and near-fatal reactions, despite regulatory actions taken by NAFDAC to suspend certain products linked to safety concerns.
Over the past months, relatives of affected patients have recounted distressing experiences of sudden health deterioration shortly after drug administration. In some cases, patients were rushed back to hospitals in critical condition.
“I was given Amoxicillin after being discharged for a minor infection. Two days later, I started feeling dizzy and confused. I collapsed at home and was rushed to the hospital. The doctors said it might be a reaction to the drugs. It was terrifying,” said 34-year-old trader in Lagos, Arowosaye Lawal.
Another patient, Chinedu Okafor, whose younger brother was admitted after suffering convulsions, said the family was shocked. “We followed the doctor’s prescription exactly. After taking the drug, he started shaking and became unconscious. We almost lost him. We want to know why these medicines are still being given out when there are warnings,” he said.
Moreover, a senior NAFDAC official, who spoke to BUSINESSDIARY but declined to be named because he is not autheoised to speak to press said, enforcement remains a major challenge. “We have intensified market surveillance, but Nigeria’s drug distribution system is complex. Some hospitals still have old stock, while others may unknowingly source medicines from unapproved suppliers. This is why we continue to urge healthcare facilities to verify their supply chains and comply strictly with regulatory directives,” the official said.
Medical practitioners say the reported cases are unusual and worrying. a consultant physician in Lagos, Dr. Henry Omotehinse,
explained that, while Amoxicillin is generally considered safe when properly produced and prescribed, severe reactions could indicate deeper issues.
According to him, “Seizures are not a common side effect of standard Amoxicillin. When we see such presentations, we immediately suspect drug quality problems, contamination, wrong dosage, or dangerous drug interactions.”
He added that, many hospitals have started reviewing their antibiotic prescriptions. “In our facility, we now double-check the source of medications and are more cautious in prescribing antibiotics that are under regulatory review. Where necessary, we switch to safer alternatives,” he said.
Similarly, a clinical pharmacologist in Lagos, Dr. Ronke Adeyemi, stressed the importance of pharmacovigilance. She said, “Doctors are now being encouraged to report every suspected adverse drug reaction to hospital drug committees and NAFDAC.”
“Unfortunately, underreporting is still a problem. Without proper documentation, it becomes difficult to track patterns and respond effectively,” she said.
BUSINESSDIARY can report that some hospital administrators admit the situation has created confusion among healthcare workers and patients. A medical director of a private hospital in Songo-Ota, Ogun State said, facilities sometimes struggle with inconsistent drug availability.
“There are times when alternative antibiotics are scarce or more expensive. This creates pressure on doctors, especially in emergency situations. However, patient safety must come first, and regulatory advisories must be respected,” he said.
Health experts warn that, continued reports of drug-related complications could erode public confidence in the healthcare system. “When patients begin to fear prescribed medication, it becomes a serious public health issue. The government must strengthen drug regulation, tighten border controls, and dismantle illegal supply chains that allow fake and substandard medicines into the market,” said health policy analyst, Dr. Aloysius Agbo.
In the meantime, the Nigerian Medical Association (NMA) has called for stronger collaboration between regulators and healthcare providers.
According to the association’s spokesperson, Dr. Benjamin Egbo, has cautioned that doctors must stay updated on regulatory notices, while hospital management must ensure procurement from verified sources.
At the same time, according to him, NAFDAC needs greater logistical support to expand surveillance and enforcement nationwide.
NAFDAC has reiterated its call for patients and healthcare professionals to report suspected adverse drug reactions through official channels.
The agency said, it is increasing inspections of pharmacies, drug distributors and health facilities as part of its post-market surveillance efforts.
As investigations continue, patients and families affected by the incidents are demanding accountability and transparency. “We just want to be safe when we go to the hospital. No one should almost die from taking medicine meant to heal them,” said a mother of two in Port Harcourt, Mrs. Blessing Okogbue.
With lives at stake, experts say urgent action is needed to ensure that only safe, approved medicines reach Nigerian patients and that regulatory directives are fully enforced across the healthcare system.


